LTX-315 (Oncopore™): A short synthetic anticancer peptide and novel immunotherapeutic agent

por Camilio, Ketil André, Rekdal, Øystein, Sveinbjörnsson, Baldur
Publicado 2014

Complete regression and systemic protective immune responses obtained in B16 melanomas after treatment with LTX-315

por Camilio, Ketil André, Berge, Gerd, Ravuri, Chandra Sekhar, Rekdal, Øystein, Sveinbjørnsson, Baldur
Publicado 2014

The Cytolytic Amphipathic β(2,2)-Amino Acid LTX-401 Induces DAMP Release in Melanoma Cells and Causes Complete Regression of B16 Melanoma

por Eike, Liv-Marie, Mauseth, Brynjar, Camilio, Ketil André, Rekdal, Øystein, Sveinbjørnsson, Baldur
Publicado 2016

Ionizing radiation abrogates the pro-tumorigenic capacity of cancer-associated fibroblasts co-implanted in xenografts

por Grinde, Maria Tunset, Vik, Jørg, Camilio, Ketil André, Martinez-Zubiaurre, Inigo, Hellevik, Turid
Publicado 2017

The Novel Oncolytic Compound LTX-401 Induces Antitumor Immune Responses in Experimental Hepatocellular Carcinoma

por Mauseth, Brynjar, Camilio, Ketil André, Shi, Jihua, Hammarström, Clara Louise, Rekdal, Øystein, Sveinbjørnsson, Baldur, Line, Pål-Dag
Publicado 2019

Cancer-Associated Fibroblasts from Lung Tumors Maintain Their Immunosuppressive Abilities after High-Dose Irradiation

por Gorchs, Laia, Hellevik, Turid, Bruun, Jack-Ansgar, Camilio, Ketil-Andre, Al-Saad, Samer, Stuge, Tor-Brynjar, Martinez-Zubiaurre, Inigo
Publicado 2015

Oncolytic peptides DTT-205 and DTT-304 induce complete regression and protective immune response in experimental murine colorectal cancer

por Fleten, Karianne Giller, Eksteen, J. Johannes, Mauseth, Brynjar, Camilio, Ketil André, Vasskog, Terje, Sveinbjørnsson, Baldur, Rekdal, Øystein, Mælandsmo, Gunhild M., Flatmark, Kjersti
Publicado 2021